Cancer Center News

Your child will be cared for by one of the most accomplished teams of childhood cancer experts in the world. We provide medical care, emotional counseling and much more. We make sure your child, you and every family member get the highest level of support.

How we serve you

Existing patients or family members

215-590-3025

New patients, referrals and second opinions

267-426-0762

CHOP Researchers Refine Experimental Prodrug Treatment of High-Risk Neuroblastoma

Mar 14, 2022

CHOP researchers have shown that linking a tumor-killing prodrug to a macromolecular carrier of the Poloxamer family improves retention of the drug in treatment-resistant neuroblastoma tumors.

CHOP-Led Study Finds Bortezomib Improves Survival in Children with Newly Diagnosed T-Cell Lymphoblastic Lymphoma

Mar 10, 2022

In a COG trial, CHOP researchers found adding bortezomib to chemotherapy significantly improved overall survival in children and young adults with newly diagnosed T-cell lymphoblastic lymphoma (T-LL).

Children’s Hospital of Philadelphia Receives $650,000 Donation to Advance Brain Tumor Research and Discoveries Within the Children’s Brain Tumor Network

Mar 2, 2022

The Lilabean Foundation’s support will accelerate pace of translational research, discovery of new treatments for children and young adults with brain tumors.

The Cancer Center Celebrates Women’s History Month

Feb 22, 2022

As we recognize women’s contributions to history during March, meet a few of the inspiring women on the Cancer Center’s team.

CHOP Study Shows Chemotherapy-Resistant Neuroblastoma Cells Have More Active Inflammatory Sensing and Signaling

Feb 7, 2022

CHOP researchers have found that chemo-resistant mesenchymal cells in neuroblastoma might be vulnerable to immunotherapy.

CHOP/Penn Study Shows CAR-T Cells Remain Active a Decade After Infusion

Feb 2, 2022

A new study in Nature has documented the longest persistence of CAR T cell therapy to date.

Q&A with Dr. Tracey Jubelirer

Jan 28, 2022

Tracey Jubelirer, MD, is the Medical Director of the inpatient oncology unit at the Middleman Family Pavilion at Children’s Hospital of Philadelphia, King of Prussia.

CHOP Researchers Define a 3-Tiered Molecular Classification of Pediatric Differentiated Thyroid Cancer, where Fusion Oncogenes Predict the Most Invasive Behavior

Jan 27, 2022

CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.

Yoga and Oncology

Jan 20, 2022

To help children through cancer treatment, yoga therapy is offered at our Voorhees and King of Prussia Specialty Care Centers.

Researchers Point to Need for Implementation Science in Pediatric Oncology

Jan 19, 2022

CHOP researchers have found that implementation science is underused in pediatric oncology and call for more research in this area to improve patient care.

Find a research study

Innovation and your child

Find research studies